To include your compound in the COVID-19 Resource Center, submit it here.

FDA releases draft guidance on imaging endpoints

FDA released draft guidance on the recommended procedures for collecting and interpreting medical images in efficacy trials of drug or biologic candidates. The

Read the full 238 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE